About Olema Oncology
Olema Oncology, also known as Olema Pharmaceuticals, Inc., was established in 2007. We operate in the Biotechnology Research industry and specialize in pharmaceuticals, biotechnology, drug development, oncology, breast cancer, nuclear receptors, and small molecules.
We discover, develop, and commercialize targeted therapies for breast cancer and endocrine-driven tumors.
Our lead program is palazestrant (OP-1250), an oral medicine that is a complete estrogen receptor antagonist (CERAN). We are developing this therapy for metastatic breast cancer. Our pipeline also includes OP-3136, a potent, selective oral inhibitor targeting the KAT6 pathway.
Mission & Values
Our mission is to improve patient care for breast cancer and other endocrine-driven tumors. We are dedicated to impacting breast cancer by pursuing treatments that help patients feel better, longer.
We strive to create effective, safe, and convenient medicines. Our team is passionate about addressing the disease.
Team & Culture
Olema Oncology has a team of 51-200 employees. The company fosters a culture of collaboration and inclusion. We believe diverse experiences and perspectives lead to groundbreaking ideas. We value every voice, celebrate diversity, and provide equal opportunities for all employees and applicants.
Our work environment is open, flexible, and supportive, empowering team members for long-term career development. Employees work in a fast-paced, cross-functional environment. Some roles are hybrid, requiring on-site presence in San Francisco, CA or Cambridge, MA.
Benefits & Perks
We offer competitive compensation and benefits, including equity and bonus opportunities. Our comprehensive benefits support long-term career development within an open, flexible, and friendly work environment.
Frequently Asked Questions
Olema Oncology is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and other endocrine-driven tumors. Their lead program, palazestrant (OP-1250), is an oral complete estrogen receptor antagonist (CERAN) initially in development for metastatic breast cancer. The company’s pipeline also includes OP-3136, an oral inhibitor of the KAT6 pathway.
Olema Oncology offers a competitive compensation and benefits package, which includes equity and bonus opportunities. The company provides comprehensive benefits and an open, flexible, and friendly work environment designed to empower employees and support long-term career development.
Olema Oncology fosters a culture of collaboration, understanding, and inclusion, believing that groundbreaking ideas stem from diverse experiences, backgrounds, and perspectives. They value every voice, celebrate diversity, and are committed to providing equal opportunities. The work environment is described as open, flexible, and supportive, aimed at empowering team members and supporting long-term career development within a fast-paced setting.
Olema Oncology’s key objective is to elevate patient care in breast cancer and beyond. The company’s mission involves pursuing better treatments that help patients feel better, longer, through the creation of more effective, safe, and convenient medicines.
Olema Oncology was founded in 2007.
Olema Oncology is active in the Pharmaceuticals, Biotechnology, Drug Development, Oncology, Breast Cancer, Nuclear Receptors, and Small Molecules markets.
Olema Oncology has 51-200 employees.
Olema Oncology hires in 🇺🇸 United States.
Yes! Olema Oncology is actively hiring with 2 open remote jobs available now.
Yes, Olema Oncology is a remote-first company.
Olema Oncology's website is olema.com .
You can find Olema Oncology on X (Twitter) and LinkedIn .
2 remote jobs at Olema Oncology
Explore latest remote opportunities and join a team that values work flexibility.
Remote companies like Olema Oncology
Find your next opportunity with companies that specialize in Pharmaceuticals, Biotechnology, Drug Development, and Oncology. Explore remote-first companies like Olema Oncology that prioritize flexible work and home-office freedom.
Day One Biopharmaceuticals
Develops targeted cancer treatments for children and adults.
Kyowa Kirin, Inc.- U.S.
A global specialty pharmaceutical company focused on discovering and delivering novel medicines using biotechnologies.
Recursion
A clinical stage TechBio company using AI and machine learning for drug discovery and development.
Ascendis Pharma
A global biopharmaceutical company developing therapies for rare endocrine diseases and cancer using its TransCon technology platform.
CellCarta
Provides precision medicine testing services and biomarker research for drug development.
Kura Oncology, Inc.
Developing precision medicines for cancer treatment
Project: Career Search
Rev. 2026.2
[ Remote Jobs ]
Direct Access
We source jobs directly from 21,000+ company career pages. No intermediaries.
Discover Hidden Jobs
Unique jobs you won't find on other job boards.
Advanced Filters
Filter by category, benefits, seniority, and more.
Priority Job Alerts
Get timely alerts for new job openings every day.
Manage Your Job Hunt
Save jobs you like and keep a simple list of your applications.